Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Elphogene, s.r.o. logo — Společnost poskytuje unikátní molekulární test oncoMonitor™...

Elphogene, s.r.o.

Společnost poskytuje unikátní molekulární test oncoMonitor™ pro sledování průběhu a léčby nádorového onemocnění.

Founded 2018 Czech Republic Czech Republic 6 employees Seed Total: $500.00K Biotechnology, Health Care +1

General Information

Company Name Elphogene, s.r.o.
Founded Year 2018
Location Czech Republic Czech Republic
Employees 6
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Elphogene, s.r.o.. To contact Elphogene, s.r.o., visit elphogene.cz.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Elphogene, s.r.o. compare?

A PDF of Elphogene, s.r.o. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Elphogene, s.r.o. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Elphogene, s.r.o.

Elphogene, s.r.o. is a Prague-based biotechnological start-up founded in 2018 as a spin-off from the Genomac Research Institute. The company's flagship project, oncoMonitor™, was introduced in 2019, aiming to monitor circulating tumor DNA (ctDNA) in cancer patients. The diagnostic tool, based on liquid biopsy, was developed in the Czech Republic after a decade of research and collaboration with leading oncology centers. The technology has shown promising results, capturing ctDNA in up to 88% of patients with advanced colorectal cancer and liver metastases. Elphogene, s.r.o. recently received a $250.00K Seed Round investment in April 2020 from i&i Prague. The company operates in the Biotechnology and Health Care industries, with a focus on advancing cancer diagnostics and treatment monitoring. This start-up's innovative approach to cancer care and the recent investment from i&i Prague position it as a promising player in the biotech industry.

Business keywords: molecular diagnostics, oncology, liquid biopsy, ctDNA, cancer monitoring, cancer treatment, start-up, Genomac, technological innovation, clinical studies, Prague, spin-off company, metastatic cancer

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $250.00K 1
i&i Prague
i&i Prague
01 Apr 2020
Pre Seed Round $250.00K 1
i&i Prague
i&i Prague
05 Apr 2019

Elphogene, s.r.o. Alternatives & Competitors

View All Alternatives
Elphogene, s.r.o. vs
Biocept, Inc.
Biocept, Inc. United States

Helping physicians improve outcomes for metastatic cancer patients by delivering advanced diagnostic...

Post-IPO Equity
49 employees
Biotechnology, Health Care
Elphogene, s.r.o. vs
Biodesix, Inc.
Biodesix, Inc. United States

Leading Diagnostic Solutions Company | Nasdaq: BDSX | 2026 & 2025 & 2024 Top Workplaces Award Winner

Post-IPO Equity
356 employees
Biotechnology, Health Care
Elphogene, s.r.o. vs
Fast MDx Ltd
Fast MDx Ltd United Kingdom

Molecular Diagnostic for Everyone

3 employees
Biotechnology, Health Care
View all alternatives

FAQ About Elphogene, s.r.o.

Společnost poskytuje unikátní molekulární test oncoMonitor™ pro sledování průběhu a léčby nádorového onemocnění.
Elphogene, s.r.o. was founded in 2018.
Elphogene, s.r.o. is headquartered in Czech Republic.
Elphogene, s.r.o. operates in Biotechnology, Health Care and Life Sciences. Its work centres on molecular diagnostics, oncology, liquid biopsy and ctDNA.
Elphogene, s.r.o. has approximately 6 employees.
Elphogene, s.r.o. has completed 2 funding rounds, raising a total of $500.00K. The latest funding stage is Seed.
Top alternatives and competitors to Elphogene, s.r.o. include Biocept, Inc. , Biodesix, Inc., Fast MDx Ltd, GeneCast Biotechnology Co., Ltd., CellMax Life. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Elphogene, s.r.o. and Biocept, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Elphogene, s.r.o., https://bouncewatch.com/company/elphogene-sro, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout